Skip to content
Advertisement

In this Sunday, Aug. 15, 2021 file photo, vials of the Moderna COVID-19 vaccine are seen at the Assad Iben El Fourat school in Oued Ellil, outside Tunisa. The European Medicines Agency said a booster dose of Moderna’s coronavirus vaccine “can be considered” in people aged 18 and above. In a statement on Monday, Oct. 25, the EU drug regulator said its analysis had shown that a third dose given of Moderna’s vaccine - which is usually given in a two-dose schedule - at least six months after the second dose, led to an increase in antibody levels in adults whose levels were waning. (AP Photo/Hassene Dridi, file)FILE

In this Sunday, Aug. 15, 2021 file photo, vials of the Moderna COVID-19 vaccine are seen at the Assad Iben El Fourat school in Oued Ellil, outside Tunisa. The European Medicines Agency said a booster dose of Moderna’s coronavirus vaccine “can be considered” in people aged 18 and above. In a statement on Monday, Oct. 25, the EU drug regulator said its analysis had shown that a third dose given of Moderna’s vaccine - which is usually given in a two-dose schedule - at least six months after the second dose, led to an increase in antibody levels in adults whose levels were waning. (AP Photo/Hassene Dridi, file)FILE

Featured Photo Galleries